cancerous lung tissue; paracancerous lung tissue; subcutaneous tumors; lung tissues
A549; H1299; H226; H460; H661; SK-MES-1; BEAS-2B
cell line-derived xenograft
proliferation (inhibits); cell cycle (inhibits); apoptosis (promotes); mitochondrial function (other pathway/process); other pathway/process (other)
Back-Splice Junction PCR / divergent primers PCR; RT-qPCR; FISH / smFISH; RNA Pull-Down; Western Blot; Luciferase Reporter Assay; Transfection; Co-IP; ChIP / ChIP-seq; MeRIP / MeRIP-seq; RIP (RNA Immunoprecipitation); Flow Cytometry(Non-apoptosis/cycle); CCK8; EdU Staining; Cell Cycle Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Wound Healing Assay; In Vivo Animal Model; H&E Staining; IHC (Immunohistochemistry); Bioinformatics Analysis
circNOL10 expression is significantly lower in lung cancer tissues and differs by histological type and differentiation degree.
circNOL10 is down-regulated in lung cancer and functions as a tumor suppressor. It directly interacts with SCML1 to inhibit SCML1 ubiquitination, increases SCML1 expression, and enhances SCML1-mediated transcription of the humanin polypeptide family (e.g., HN2/HN8), leading to altered mitochondrial function and reduced proliferation/cell-cycle progression with increased apoptosis.
0.8096
Circular RNA circNOL10 Inhibits Lung Cancer Development by Promoting SCLM1-Mediated Transcriptional Regulation of the Humanin Polypeptide Family.
combined biological and clinical study